Small airways ventilation heterogeneity and hyperinflation in COPD: Response to tiotropium bromide

International Journal of COPD

Volumn 2, Issue 4, 2007, Pages 625-634

  Verbanck, Sylvia ^a   Schuermans, Daniël ^a   Vincken, Walter ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

COPD; Hyperinflation; Small airways; Ventilation heterogeneity

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG; STEROID; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG VENTILATION; MALE; MORNING DOSAGE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

AGED; BELGIUM; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 38049171310     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Barnes PJ, Belvisi MG, Mak JC, et al. 1995. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci, 56:853-9.
2. Celli B, ZuWallack R, Wang S, et al. 2003. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest, 124:1743-8.
3. Verkindre C, Bart F, Aguilaniu B, et al. 2006. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Respiration, 73:420-7.
4. Brusasco V, Hodder R, Miravitlles M, et al. 2003. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax, 58:399-404.
5. Vincken W, van Noord JA, Greefhorst AP, et al. 2002. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J, 19:209-16.
6. Casaburi R, Mahler DA, Jones PW, et al. 2002. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J, 19:217-24.
7. van Noord JA, Bantje TA, Eland ME, et al. 2000. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax, 55:289-94.
8. Casaburi R, Kukafka D, Cooper CB, et al. 2005. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest, 127:809-17.
9. O'Donnell DE, Fluge T, Gerken F, et al. 2004. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J, 23:832-40.
10. Maltais F, Hamilton A, Marciniuk D, et al. 2005. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest, 128:1168-78.
11. Dusser D, Bravo ML, Iacono P. 2006. The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J, 27:547-55.
12. Niewoehner DE, Rice K, Cote C, et al. 2005. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med, 143:317-26.
13. Gross NJ. 2004. Tiotropium bromide. Chest, 126:1946-53.
14. Barnes PJ. 2004. Distribution of receptor targets in the lung. Proc Am Thorac Soc, 1:345-51.
15. Verbanck S, Schuermans D, Meysman M, et al. 2004. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med, 170:414-19.
16. Verbanck S, Schuermans D, Van Muylem A, et al. 1997. Ventilation distribution during histamine provocation. J Appl Physiol, 83:1907-16.
17. Verbanck S, Schuermans D, Van Muylem A, et al. 1998. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. Am J Respir Crit Care Med, 157:1573-7.
18. Verbanck S, Schuermans D, Noppen M, et al. 1999. Evidence of acinar airway involvement in asthma. Am J Respir Crit Care Med, 159:1545-50.
19. Rodenstein DO, Stanescu DC. 1982. Reassessment of lung volume measurement by helium dilution and by body plethysmography in chronic air-flow obstruction. Am Rev Respir Dis, 126:1040-4.